The CAR-CCR9, a CAR-T with a single-chain variable fragment (scFv) for hCCR9, demonstrated cytotoxicity against CCR9-positive but not CCR9-negative T-ALL cells [21]. Here, CCR9 is linked to acute lymphoblastic leukemia.